Current insight into the roles of microRNA 25-5p and microphthalmia-associated transcription factor in the pathogenesis of non-segmental vitiligo

Assessment of Interleukin-12 Gene Polymorphism in Vitiligo Patients

Evaluation of Interleukin-23 Receptor Gene Polymorphism in Vitiligo Patients

Role of Isocitrate Dehydrogenase 2, Microphthalmia-Associated Transcription Factor and Alpha Melanocyte Stimulating Hormone in Patients with Non-Segmental Generalized Vitiligo

A Study of Plasma miR-23a Expression in Vitiligo Patients

Serum Interleukin 19 in Patients with Vitiligo

Serum CCL20 Level in Patients with Vitiligo

Serum level of YKL-40, C-reactive protein and ESR in Patients with Vitiligo

Measurement of Serum Prolactin Level in Vitiligo Patients and its Correlation with Prolactin Gene Polymorphism

Serum MicroRNA-155 Expression Level as a Novel Biomarker in Alopecia Areata Patients